Zinc Monotherapy as an Alternative Treatment Option for Decompensated Liver Disease due to Wilson Disease?
Authors:
Open Access
- 14 January 2020
- journal article
- case report
- Published by Wiley in Case Reports in Hepatology
- Vol. 2020, 1-5
Abstract
Background. Wilson disease is a rare metabolic disorder involving copper metabolism, and patients may present with a variable degree of hepatic, neurologic, and psychiatric manifestations. In the case of hepatic presentation, treatment is usually initiated with potentially toxic copper chelators (D-penicillamine or Trenton). Although zinc is of low toxicity and low cost for treatment of Wilson disease, it has been limited to the adjunctive as a single maintenance drug or for asymptomatic patients. The use of zinc monotherapy in patients suffering from a severe liver disease was not well studied. In our case report, we describe a pediatric patient who presented with liver failure and the use of zinc monotherapy in patients with severe hepatic manifestations. Case presentation. A 15-year-old male patient from Ethiopia presented with generalized body swelling (edema and ascites) with yellowish discoloration of his eyes and easy fatigability. He had hyperbilirubinemia, coagulopathy, hypoalbuminemia, and deranged liver enzymes. He had a Keyser–Fleischer ring visible with the naked eye, which was confirmed by slit-lamp examination. He had very low serum ceruloplasmin (Conclusion. Our case shows that zinc has the potential for treatment in improving liver function. Though zinc has its own side effects, it is important and maybe an alternative treatment option in those with limited resources (not able to access chelators). This example hopefully will encourage future investigations and researches on zinc monotherapy for treating symptomatic decompensated hepatic Wilson disease.Keywords
This publication has 16 references indexed in Scilit:
- Zinc Therapy for Wilson Disease in Children in French Pediatric CentersJournal of Pediatric Gastroenterology and Nutrition, 2015
- Late onset fulminant Wilson’s disease: A case report and review of the literatureWorld Journal of Gastroenterology, 2014
- A Review and Current Perspective on Wilson DiseaseJournal of Clinical and Experimental Hepatology, 2013
- Wilson disease in a Nigerian child: a case reportJournal of Medical Case Reports, 2012
- Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson diseaseAlimentary Pharmacology & Therapeutics, 2009
- Screening for Wilson disease in acute liver failureHepatology, 2008
- Resolution of Decompensated Cirrhosis From Wilson’s Disease With Zinc Monotherapy: A Potential Therapeutic Option?Clinical Gastroenterology and Hepatology, 2006
- Diagnosis and treatment of Wilson's diseasePediatric Transplantation, 2002
- Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10‐year‐old childActa Paediatrica, 1992
- TREATMENT OF WILSONS-DISEASE WITH ZINC .6. INITIAL TREATMENT STUDIES1989